Joel Greenblatt acquired 10.3 Thousand Supernus Pharmaceuticals shares worth $282 Thousand. That's 0.01% of their equity portfolio (920th largest holding). The first Supernus Pharmaceuticals trade was made in Q1 2015. Since then Joel Greenblatt bought shares ten more times and sold shares on fourteen occasions. The investor's estimated purchase price is $326 Thousand, resulting in a loss of 14%.